Article

A cold sore after microneedling? When to get a new blister assessed

The FDA lists cold-sore reactivation as a possible risk of microneedling. A new blister still needs its own assessment, especially when it is near an eye or accompanied by eye symptoms.

3 min read Published Source checked

Pink and white tissue paper beneath a pane on navy fabric
Treomark original AI-generated editorial image

Microneedling can be followed by cold-sore reactivation, a risk the FDA lists. A new blister does not confirm herpes simplex or establish that the procedure caused it. Contact the treating clinician right away to have a new blister or cluster assessed. Get urgent medical assessment for eye pain, a worsening red eye or a vision change. Get emergency care for a red eye that hurts when you look at light.123

Start with the visible change, not the suspected diagnosis

The FDA lists common reactions such as redness and tightness separately from less common risks such as infection or cold-sore reactivation. A diffuse change across the treated area and a new cluster of blisters are different observations. When you call, describe what changed, its location and how it differs from earlier episodes. If you have never had a cold sore, say so. If you have, explain whether the new change resembles a clinician-confirmed episode or only a symptom you suspect is the same.12

A photo can help communicate where the change is and how it looks. It cannot determine the cause by itself. The dermatologist’s decision may depend on what the person can see at an examination and whether a test would be useful. Ask where the practice wants you to be evaluated and what procedure information it can give that clinician. Treomark’s microneedling recovery guide covers the broader question of expected recovery.12

A change involving the eye needs a different handoff

An eyelid-area blister and a symptom in the eye are not interchangeable. Tell the person taking the call if the eye itself hurts, redness is getting worse, light is difficult to tolerate or vision is blurry. Do not wait for the cosmetic practice to identify a skin lesion before seeking urgent assessment for one of those eye symptoms. The NHS distinguishes eye pain, worsening redness and a vision change as urgent from a red eye that hurts when you look at light, which needs emergency care. These symptoms still need assessment for other causes.3

What to report after the procedure
ObservationWhat to tell the clinician
Where it isWhether it affects the treated skin, the eyelid, the eye or another area.
What changedDescribe a single lesion, a group of blisters, redness or another finding in your own words.
Earlier historyAny previously diagnosed cold sores or eye infection, and how the new change compares.
Treatment recordThe device and any products used, plus the practice that can send the record.

Keep other exposures on the same record

A visit may involve more than the device, including a product used on the skin or a topical anesthetic. Name those separately if you have the information. If the clinician is considering a skin infection, irritation or another cause, a list of products and the treatment area gives them more to work with than a photo alone. If you used another product after the visit, report that as a separate exposure rather than trying to identify the cause yourself.12

If another clinician evaluates the change, ask the original practice to send the treatment record. That can avoid losing the exact device or product name between offices.1

Before another visit, clarify who owns the follow-up

The FDA’s listing is a safety signal for the procedure category, not a reliable rate for a particular model, cartridge or group of patients. A practice should not promise that a different device eliminates a history-related concern. If you compare microneedling practices, ask who reviews your documented history and how the office would coordinate with dermatology or eye care if a new symptom occurs. An explanation of the care handoff is more useful than a promise that any blister will be easy to recognize.123

Sources

  1. U.S. Food and Drug Administration. Microneedling Devices. Lists common effects and less common risks including cold-sore reactivation; flags active infections and relevant history for clinician assessment. Accessed .
  2. American Academy of Dermatology. Cold sores: Diagnosis and treatment. Describes clinical evaluation of suspected cold sores and when healthcare assessment is appropriate. Accessed .
  3. NHS. Herpes simplex eye infections. Distinguishes urgent eye pain, worsening redness or a vision change from a red eye with painful light sensitivity, an emergency sign. Accessed .
Built from the public records listed above. Spot an error? Report a correction